These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26870228)

  • 1. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.
    Yuan WX; Gui YX; Na WN; Chao J; Yang X
    Oncol Lett; 2016 Jan; 11(1):423-432. PubMed ID: 26870228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphoma.
    Chen L; Kan Y; Wang X; Ge P; Ding T; Zhai Q; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Liu X; Li L; Qiu L; Zhang H; Qian Z; Zhao H
    Oncol Lett; 2020 Oct; 20(4):93. PubMed ID: 32831912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
    Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
    J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
    Beheshti A; Stevenson K; Vanderburg C; Ravi D; McDonald JT; Christie AL; Shigemori K; Jester H; Weinstock DM; Evens AM
    Sci Rep; 2019 Nov; 9(1):17161. PubMed ID: 31748664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients.
    Song G; Gu L; Li J; Tang Z; Liu H; Chen B; Sun X; He B; Pan Y; Wang S; Cho WC
    Ann Hematol; 2014 Oct; 93(10):1735-43. PubMed ID: 24858372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance.
    Feng Y; Zhong M; Zeng S; Wang L; Liu P; Xiao X; Liu Y
    Epigenomics; 2019 Jan; 11(1):35-51. PubMed ID: 30211623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin.
    Sun N; Wang CY; Sun YQ; Ruan YJ; Huang YY; Su T; Zhou XH; Huang H; Guo WJ; He MQ; Yao RX; Lin XJ
    Biomed Pharmacother; 2018 Oct; 106():267-274. PubMed ID: 29966970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
    Yang JM; Jang JY; Jeon YK; Paik JH
    J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF
    Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma.
    Due H; Schönherz AA; Ryø L; Primo MN; Jespersen DS; Thomsen EA; Roug AS; Xiao M; Tan X; Pang Y; Young KH; Bøgsted M; Mikkelsen JG; Dybkær K
    Blood Adv; 2019 Apr; 3(7):1185-1196. PubMed ID: 30967394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
    Cao QW; Li HY; Yao XX; Wang JF
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
    Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA
    Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Biomarkers in Canine Diffuse Large B-Cell Lymphoma.
    Elshafie NO; Nascimento NCD; Lichti NI; Kasinski AL; Childress MO; Santos APD
    Vet Pathol; 2021 Jan; 58(1):34-41. PubMed ID: 33287683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated expression of miR-224 and its target gene: CD59 predicts outcome of diffuse large B-cell lymphoma patients treated with R-CHOP.
    Song G; Song G; Ni H; Gu L; Liu H; Chen B; He B; Pan Y; Wang S; Cho WC
    Curr Cancer Drug Targets; 2014; 14(7):659-70. PubMed ID: 25146331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma.
    Jiang Y; Luan Y; Chang H; Chen G
    Oncol Lett; 2018 Sep; 16(3):4001-4007. PubMed ID: 30128020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.
    Jia QW; Chen ZH; Ding XQ; Liu JY; Ge PC; An FH; Li LH; Wang LS; Ma WZ; Yang ZJ; Jia EZ
    Cell Physiol Biochem; 2017; 42(2):808-823. PubMed ID: 28628920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between microRNA-125b expression in formalin-fixed paraffin-embedded tumor tissues and prognosis in patients with melanoma.
    Yan J; Jiang Q; Lu H; Na S; Long S; Xin Y; Zhang C; Zhang J
    Oncol Lett; 2019 Aug; 18(2):1856-1862. PubMed ID: 31423254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma.
    Ahmadvand M; Eskandari M; Pashaiefar H; Yaghmaie M; Manoochehrabadi S; Khakpour G; Sheikhsaran F; Montazer Zohour M
    Leuk Res; 2018 Jul; 70():45-48. PubMed ID: 29807272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.